Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming L Tian, A Goldstein, H Wang, H Ching Lo, IK Sun Kim, T Welte, K Sheng, ... Nature 544 (7649), 250-254, 2017 | 713 | 2017 |
The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells H Wang, C Yu, X Gao, T Welte, AM Muscarella, L Tian, H Zhao, Z Zhao, ... Cancer cell 27 (2), 193-210, 2015 | 376 | 2015 |
Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation T Welte, IS Kim, L Tian, X Gao, H Wang, J Li, XB Holdman, ... Nature cell biology 18 (6), 632-644, 2016 | 217 | 2016 |
The osteogenic niche is a calcium reservoir of bone micrometastases and confers unexpected therapeutic vulnerability H Wang, L Tian, J Liu, A Goldstein, I Bado, W Zhang, BR Arenkiel, Z Li, ... Cancer cell 34 (5), 823-839. e7, 2018 | 130 | 2018 |
Structural basis for distinct roles of SMAD2 and SMAD3 in FOXH1 pioneer-directed TGF-β signaling E Aragón, Q Wang, Y Zou, SM Morgani, L Ruiz, Z Kaczmarska, J Su, ... Genes & development 33 (21-22), 1506-1524, 2019 | 87 | 2019 |
Flura-seq identifies organ-specific metabolic adaptations during early metastatic colonization H Basnet, L Tian, K Ganesh, YH Huang, DG Macalinao, E Brogi, ... Elife 8, e43627, 2019 | 70 | 2019 |
Wild-type N-Ras, overexpressed in basal-like breast cancer, promotes tumor formation by inducing IL-8 secretion via JAK2 activation ZY Zheng, L Tian, W Bu, C Fan, X Gao, H Wang, YH Liao, Y Li, MT Lewis, ... Cell reports 12 (3), 511-524, 2015 | 49 | 2015 |
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial F Wang, Y Jin, M Wang, HY Luo, WJ Fang, YN Wang, YX Chen, ... Nature Medicine 30 (4), 1035-1043, 2024 | 47 | 2024 |
Bone-in-culture array as a platform to model early-stage bone metastases and discover anti-metastasis therapies H Wang, L Tian, A Goldstein, J Liu, HC Lo, K Sheng, T Welte, STC Wong, ... Nature communications 8 (1), 15045, 2017 | 41 | 2017 |
Hormonal modulation of ESR1 mutant metastasis G Gu, L Tian, SK Herzog, Y Rechoum, L Gelsomino, M Gao, L Du, JA Kim, ... Oncogene 40 (5), 997-1011, 2021 | 35 | 2021 |
AIMp1 Potentiates TH1 Polarization and Is Critical for Effective Antitumor and Antiviral Immunity D Liang, L Tian, R You, MM Halpert, V Konduri, YC Baig, S Paust, D Kim, ... Frontiers in immunology 8, 1801, 2018 | 34 | 2018 |
An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma YX Chen, ZX Wang, Y Jin, Q Zhao, ZX Liu, ZX Zuo, HQ Ju, C Cui, J Yao, ... Cancer Cell 41 (5), 919-932. e5, 2023 | 19 | 2023 |
Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain S Gan, DG Macalinao, SH Shahoei, L Tian, X Jin, H Basnet, C Bibby, ... Cancer cell 42 (10), 1693-1712. e24, 2024 | 6 | 2024 |
The Y537S ESR1 mutation is a dominant driver of distant ER-positive breast cancer metastasis G Gu, L Tian, M Gao, Y Rechoum, L Gelsomino, D Dustin, ... Cancer Research 78 (13_Supplement), 22-22, 2018 | 6 | 2018 |
优质稻米 ‘青香软粳’低直链淀粉含量形成分子机制的初步研究 李凌, 田麟, 王涛涛, 蒋其根, 罗治靖, 陈明姣, 张建中, 张大兵, 袁政 植物生理学报 48 (2), 147-155, 2012 | 6 | 2012 |
Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry Y Zhou, Y Zhang, M Li, T Ming, C Zhang, C Huang, J Li, F Li, H Li, E Zhao, ... Science Immunology 9 (100), eado8758, 2024 | 2 | 2024 |
转基因牛乳中重组人乳铁蛋白的仿生亲和纯化 文胜, 田麟, 肖天舒, 冉启迪, 董德贤, 李荣秀 中国生化药物杂志 30 (2), 73-77, 2009 | 2 | 2009 |
Alternations in inflammatory macrophage niche drive phenotypic and functional plasticity of Kupffer cells HY Huang, YZ Chen, C Zhao, XN Zheng, K Yu, JX Yue, HQ Ju, YX Shi, ... Nature Communications 15 (1), 9337, 2024 | 1 | 2024 |
Vascular‐Associated Mononuclear Phagocytes: First‐Line Soldiers Ambushing Metastasis H Huang, X Zheng, L Tian BioEssays, e202400261, 2024 | | 2024 |
Cytidine triphosphate synthase 1-mediated metabolic reprogramming promotes proliferation and drug resistance in multiple myeloma H Huang, Y Chen, Y Li, X Zheng, L Shu, L Tian, H Lin, Y Liang Heliyon 10 (13), 2024 | | 2024 |